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Background.  Enterohemorrhagic E. coli (EHEC) cause life-threatening shigellosis with disease symptoms, 
including severe colitis, intense abdominal pain, hemorrhagic diarrhea, and hemolytic uremic syndrome 
(HUS). EHEC in murine models does not cause shigellosis. However, genetically similar Citrobacter rodentium 
(Cr) is a murine pathogen with common virulence strategies, but conveniently does not infect humans.  Our 
objective was to utilize a novel Cr lysogenized by a Shiga toxin-2 phage (CrStx2) to produce a murine 
shigellosis model in which CrStx2-induced alterations to the gi tract, immune system, and kidneys can be 
delineated.  And, to investigate the potential of microbiome manipulation to ameliorate the disease.   
 
Methods.  C3H/HeN 3mo mice were orally inoculated with 109 CFU of CrStx2 with sacrifice at onset of 
sickness behavior.  MagPIX serum cytokine profiling was performed (N=5,5 each).  Colon, kidney and urinary 
bladder were removed for structural and microscopic changes (N=3,3 each).  Colonic mucosal barrier failure 
was assessed (N=4,4) and the whole-mount spatial distribution of neutrophil infiltrates within the colonic 
lamina propria (LP) and muscularis externa (ME) were characterize (N=4,4).  Functional gastrointestinal transit 
was quantified using orally fed FITC-dextran (70kD, 80min)(p-values <0.05 for significance).   
 
Results.  On post-day 5, CrStx2 mice progressively lost weight and were sacrificed on day 8.1±0.19 (N=9).  
Colons exhibited histologically mild hemorrhagic mucosal sloughing with mucosal barrier failure due to the 
copious presence of 0.4µm fluorescent microspheres within the lamina propria after oral administration 
preferentially at lymph nodules.  No microsphere transference in controls.  Spatial analysis of neutrophil 
lamina propria infiltrates demonstrated increased clustering around enlarged and more numerous lymph 
nodules (8.0±1.07 vs. cntrl=5.6±1.09, N=7,4).  CrStx2 did not increase the presence of neutrophils within the 
colonic (cntrl=2.5±0.97 vs. CrStx2=3.2±1.3, 100X) or jejunal ME vs. controls (N=3,3,4,4).  Although, upper 
gastrointestinal transit was severely delayed (4.3±0.66 vs. cntrl=9.6±1.35, N=4,4).  Serum demonstrated 
significant increases in circulating (VEGF=69.7±4.60 vs. 95.4±14.17 and IL-10=48.9±2.88 vs. 118.1±29.45) for 
control vs CrStx2, respectively.  But, not IL-1α, IL-6, GM-CSF, KC, MCP-1 (MCAF), MIP-1α, RANTES or TNF-
α) vs. control (N=5,5).  The presence of IV injected 0.1µm microspheres in the urinary bladder lumen 
demonstrated renal failure. Microbiome manipulation by daily oral administration of probiotics (30,000 CFU) 
or a nonpathogenic Cr intimin mutant (109 CFU) did not alter the pathogenesis of shigellosis.   
 
Conclusion.  We developed a safe reliable murine model of shigellosis that encompasses intestinal 
colonization and severe Stx2-mediated tissue damage, which provides an opportunity to mechanistically 
explore its pathophysiology and potential treatments.  Additionally, we concluded that microbiome 
manipulation was not successful in ameliorating the pathogenesis of shigellosis in this model.   
 
  
  
